| | Cancer | Skin Cancer
Melanoma Origins: From Melanocytes to Malignancy
Melanoma arises from melanocytes—the pigment-producing cells responsible for skin color. Understanding their biology clarifies melanoma development.
Melanocyte Biology
- Location: Primarily in the basal layer of the epidermis (every 5-10 keratinocytes); also in hair follicles, eyes, meninges, inner ear, mucosa.
- Origin: Neural crest-derived; migrate during embryogenesis.
- Function: Synthesize melanin (eumelanin = brown/black; pheomelanin = red/yellow) in melanosomes, transferred to keratinocytes for UV protection.
- Regulation: MC1R receptor activation by α-MSH (UV-induced) stimulates eumelanin production.
Melanoma Pathogenesis
Genetic Drivers
- BRAF V600E mutation: ~50% cutaneous melanomas; activates MAPK pathway.
- NRAS mutations: ~15-20%; mutually exclusive with BRAF.
- NF1 loss: ~10-15%; RAS pathway dysregulation.
- TERT promoter mutations: >70%; immortalization via telomerase.
- CDKN2A (p16) loss: Familial melanoma; cell cycle dysregulation.
- PTEN loss, TP53 mutations: Later progression events.
UV Radiation Role
UVB causes direct DNA damage (C→T transitions); UVA generates oxidative stress. Both create "UV signature" mutations. Intermittent intense exposure (sunburns) strongly correlates with trunk/leg melanomas; chronic exposure with face/neck/scalp.
Melanoma Subtypes by Origin Site
| Subtype | Primary Site | Key Features |
|---|---|---|
| Superficial spreading | Trunk (M), legs (F) | Radial growth phase; BRAF mutant |
| Nodular | Anywhere | Vertical growth from onset; aggressive |
| Lentigo maligna | Sun-damaged face/neck | Slow radial growth; elderly; UV signature |
| Acral lentiginous | Palms, soles, nail beds | Non-UV; KIT mutations; all skin types |
| Mucosal | Genital, oral, sinus | Non-UV; KIT, SF3B1 mutations |
| Uveal | Eye (choroid, ciliary body, iris) | GNAQ/GNA11 mutations; distinct biology |
Precursor Lesions
- Congenital melanocytic nevi: Large/giant (>20 cm) → 5-10% lifetime melanoma risk.
- Atypical/dysplastic nevi: Marker of increased risk; not obligate precursors.
- Melanoma in situ: Confined to epidermis; 100% curable with excision.
Melanoma is a malignancy of transformed melanocytes. Early detection (ABCDE: Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolution) and excision offer cure.
Skin Cancer - Related Articles
- Skin Cancer Prevention: Current Research Frontiers and Public Health Strategies
- Understanding Skin Cancer: Risk Factors & Demographics
- Skin Cancer Risk Factors: 11 Causes and Prevention Strategies
- Mohs Surgery: A Precise Approach to Skin Cancer Removal
- Squamous Cell Carcinoma Treatment & Cure: What You Need to Know
- Skin Melanoma: Recognizing Early Warning Signs & Symptoms
- Understanding Moles and Skin Cancer: Risks & Prevention
